Trial Profile
Cardiac Safety Profile of Caelyx Therapy in Anthracyclin Pretreated Metastatic Breast Cancer Patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 06 Nov 2008 New trial record.